PPAR-COMBO With Sulfonylurea

Completed · Phase 3

Conditions studied: Metabolics Diabetes Nos

In brief

A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 in Combination with Glyburide Therapy in Subjects with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sulfonylurea Therapy Alone.

Key facts

Study ID
NCT00162175
Run by
Bristol-Myers Squibb
People needed
534
Starts
2003-07-01
Expected to finish
2005-11-01
Last updated by the study team
2010-09-14

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.